Feng Yue
Papers
2
Total Citations
8
H-Index
2
About
Feng Yue is a pioneering urological surgeon and researcher at the forefront of robotic-assisted surgery, with a primary focus on advancing minimally invasive treatments for urologic cancers. His major contributions lie in systematically evaluating and comparing the safety, efficacy, and perioperative performance of emerging Chinese robotic surgical systems against the established global gold standard, the da Vinci Xi. In a landmark 2025 prospective study, Yue demonstrated that Chinese systems like KangDuo 2.0 achieve comparable outcomes to the da Vinci Xi in robot-assisted partial nephrectomy for early renal cancer, a finding with significant implications for reducing healthcare costs and expanding surgical access. His work has already garnered over 8 citations, reflecting its immediate impact on the field. Notably, Yue’s comparative analysis of the KangDuo 2.0 and Da Vinci Xi in radical cystectomy provides critical evidence supporting the clinical viability of domestically developed platforms, potentially reshaping urological surgical practice by offering more affordable alternatives without compromising patient safety or outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2